. Characterization of primary human glioblastoma cell populations. (A) MGMTmethylation analysis: A pyrosequencing assay was used to determine CpG methylation of the MGMT-gene. The reverse assay shows the methylation level at 8 individual CpG positions. A G (guanine) signal in this reverse assay indicates the methylated state of the cytosine of the respective CpG dinucleotide, whereas an A (adenine) signal represents the unmethylated state. Representative for all investigated primary glioblastoma cells, the pyrogram shows strong methylation of the investigated region in the G40 cell population (upper panel). A primary glioma tumor sample serves as negative control (lower panel) and shows the investigated MGMT region in an unmethylated state. (B) IDH1-and (C) IDH2-mutation analysis: Two DNA fragments spanning the hotspot regions R132 and R172 of IDH1 and IDH2 respectively were amplified by PCR and sequenced by pyrosequencing. The sequence status is depicted for the cell population G35 representative for all three investigated cell populations together with a positive control for the most frequent mutation of the IDH1 (R132H c.395G>A; p.R132H, upper panel) and IDH2 (c.515G>A; p.R172K lower panel). G, glioblastoma. control. Positive connexin-43 expression could also be detected in case of primary suspension cell populations, whereof differentiated glioblastoma cells were derived from for short term expansion. G, glioblastoma; Cx43, connexin-43. Figure S3 . Determination of effective drug concentrations. Results of the MTT assay: Differentiated glioblastoma cells were treated with various concentrations of (A) TMZ and (B) INI. Cell viability was assessed 72 and 144 hrs after treatment. Untreated controls were defined as 100%. Mean of relative cell viability of three independent experiments performed in triplicates are depicted. Error bars show SEM. Ctr, control; G, glioblastoma; TMZ, temozolomide. Figure S4 . The effects on glioblastoma cell viability. Treatment was performed using 50 μM TMZ, 100 μM INI or combination of both. Reduction of tetrazolium salt to formazan as surrogate readout for cell proliferation was determined colorimetrically 144 hrs after treatment. Untreated controls were defined as 100%. Mean ± SEM is depicted. Ctr, control; G, glioblastoma; TMZ, temozolomide. 
